106 related articles for article (PubMed ID: 10780214)
1. [The prognostic significance of 99mTc-MDP breast scintigraphy. A comparison with histological and molecular parameters].
Dimonte M; Leo G; Marsigliante S; Manca C
Radiol Med; 1999 Nov; 98(5):352-5. PubMed ID: 10780214
[TBL] [Abstract][Full Text] [Related]
2. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
[TBL] [Abstract][Full Text] [Related]
4. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
5. Acquisition protocol for breast cancer imaging with technetium-99m-labeled synthetic peptide and technetium-99m-MDP.
Fiorenza M; Prisco G; Bartolomei M; Chinol M; Cremonesi M; Leonardi L; De Cicco C; Paganelli G
J Nucl Med Technol; 1997 Sep; 25(3):191-4. PubMed ID: 9291065
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between Tc-99m-sestaMIBI uptake and cadherin expression in infiltrating ductal breast carcinoma as prognostic indicators.
Uğur Y; Sari O; Uğur O; Korkusuz P; Varoğlu E; Arslan N; Gürcan N; Yildirim M; Sökmensüer C; Aşan E; Aras T
Ann Nucl Med; 2003 Jun; 17(4):281-7. PubMed ID: 12932110
[TBL] [Abstract][Full Text] [Related]
7. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
[TBL] [Abstract][Full Text] [Related]
8. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment].
Stefănescu C; Chossiere L; Rusu V; Meignan M
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458
[TBL] [Abstract][Full Text] [Related]
9. 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis.
Turhal NS; Dane F; Dede F; Gumus M; Yumuk PF; Cakalagaoglu F; Savci D; Karaman M; Gulluoglu B; Turoglu HT
Anticancer Res; 2004; 24(3b):1999-2006. PubMed ID: 15274391
[TBL] [Abstract][Full Text] [Related]
10. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
Cistaro A; Bonazzi G; Bellò M; Bessone M; Tetti M; Villata E; Coluccia C; Bisi G; Massaioli N
Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.
Piccolo S; Lastoria S; Mainolfi C; Muto P; Bazzicalupo L; Salvatore M
J Nucl Med; 1995 May; 36(5):718-24. PubMed ID: 7738640
[TBL] [Abstract][Full Text] [Related]
13. Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy.
Yang JG; Li CL; Hao RR; Zou LF
Ann Nucl Med; 2008 Jan; 22(1):79-82. PubMed ID: 18250991
[TBL] [Abstract][Full Text] [Related]
14. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
[TBL] [Abstract][Full Text] [Related]
15. [Visualization of the female breast in bone scintigraphy].
Uno K; Uchida Y; Sakata S; Minoshima S; Okada J; Yoshikawa K; Arimizu N; Karikomi M; Kitakata Y; Suzuki Y
Kaku Igaku; 1992 Oct; 29(10):1201-6. PubMed ID: 1464959
[TBL] [Abstract][Full Text] [Related]
16. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer.
Van Den Bossche B; D'haeninck E; De Winter F; Van Belle S; Dierckx RA; Van De Wiele C
Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172
[TBL] [Abstract][Full Text] [Related]
17. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
18. Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia.
Pickhardt PJ; McDermott M
J Nucl Med; 1997 Apr; 38(4):528-30. PubMed ID: 9098196
[TBL] [Abstract][Full Text] [Related]
19. [Whole-body bone scintigraphy in the diagnosis and follow-up of the evolution of breast cancer].
Muşat E; Stefănescu C; Rusu V
Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):163-9. PubMed ID: 10756905
[TBL] [Abstract][Full Text] [Related]
20. Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
Kim SJ; Choi JY; Lee JH; Hyun SH; Cho YS; Moon SH; Choe YS; Lee KH; Kim BT
Nuklearmedizin; 2016 Aug; 55(4):166-71. PubMed ID: 26632485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]